Global Tumor Treating Fields (TTFields) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 153963
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 108
  • list Pharmaceuticals and Healthcare

Tumor Treating Field (TTField) is an anticancer treatment which disrupts the tumor cells mitosis. Tumor Treating Field is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer.

Scope of the Report:

North America is projected to hold largest shares in the global TTFields market primarily due to growing incidence and prevalence of cancer and launch and growing adoption of novel cancer therapy.

The global Tumor Treating Fields (TTFields) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tumor Treating Fields (TTFields).

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Tumor Treating Fields (TTFields) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tumor Treating Fields (TTFields) market by product type and applications/end industries.

Market Segment by Companies, this report covers

Novocure

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Low Frequency

Intermediate Frequency

Market Segment by Applications, can be divided into

Hospitals

Clinics

Cancer and Radiation Therapy Centers

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Tumor Treating Fields (TTFields) Market Overview

1.1 Product Overview and Scope of Tumor Treating Fields (TTFields)

1.2 Classification of Tumor Treating Fields (TTFields) by Types

1.2.1 Global Tumor Treating Fields (TTFields) Revenue Comparison by Types (2017-2023)

1.2.2 Global Tumor Treating Fields (TTFields) Revenue Market Share by Types in 2017

1.2.3 Low Frequency

1.2.4 Intermediate Frequency

1.3 Global Tumor Treating Fields (TTFields) Market by Application

1.3.1 Global Tumor Treating Fields (TTFields) Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Cancer and Radiation Therapy Centers

1.3.5 Others

1.4 Global Tumor Treating Fields (TTFields) Market by Regions

1.4.1 Global Tumor Treating Fields (TTFields) Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Tumor Treating Fields (TTFields) Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Tumor Treating Fields (TTFields) Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tumor Treating Fields (TTFields) Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Tumor Treating Fields (TTFields) Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tumor Treating Fields (TTFields) Status and Prospect (2013-2023)

1.5 Global Market Size of Tumor Treating Fields (TTFields) (2013-2023)

2 Manufacturers Profiles

2.1 Novocure

2.1.1 Business Overview

2.1.2 Tumor Treating Fields (TTFields) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Novocure Tumor Treating Fields (TTFields) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Tumor Treating Fields (TTFields) Market Competition, by Players

3.1 Global Tumor Treating Fields (TTFields) Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Tumor Treating Fields (TTFields) Players Market Share

3.2.2 Top 10 Tumor Treating Fields (TTFields) Players Market Share

3.3 Market Competition Trend

4 Global Tumor Treating Fields (TTFields) Market Size by Regions

4.1 Global Tumor Treating Fields (TTFields) Revenue and Market Share by Regions

4.2 North America Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

4.3 Europe Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

4.5 South America Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

5 North America Tumor Treating Fields (TTFields) Revenue by Countries

5.1 North America Tumor Treating Fields (TTFields) Revenue by Countries (2013-2018)

5.2 USA Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

5.3 Canada Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

5.4 Mexico Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

6 Europe Tumor Treating Fields (TTFields) Revenue by Countries

6.1 Europe Tumor Treating Fields (TTFields) Revenue by Countries (2013-2018)

6.2 Germany Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

6.3 UK Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

6.4 France Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

6.5 Russia Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

6.6 Italy Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Tumor Treating Fields (TTFields) Revenue by Countries

7.1 Asia-Pacific Tumor Treating Fields (TTFields) Revenue by Countries (2013-2018)

7.2 China Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

7.3 Japan Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

7.4 Korea Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

7.5 India Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

8 South America Tumor Treating Fields (TTFields) Revenue by Countries

8.1 South America Tumor Treating Fields (TTFields) Revenue by Countries (2013-2018)

8.2 Brazil Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

8.3 Argentina Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

8.4 Colombia Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Tumor Treating Fields (TTFields) by Countries

9.1 Middle East and Africa Tumor Treating Fields (TTFields) Revenue by Countries (2013-2018)

9.2 Saudi Arabia Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

9.3 UAE Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

9.4 Egypt Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

9.5 Nigeria Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

9.6 South Africa Tumor Treating Fields (TTFields) Revenue and Growth Rate (2013-2018)

10 Global Tumor Treating Fields (TTFields) Market Segment by Type

10.1 Global Tumor Treating Fields (TTFields) Revenue and Market Share by Type (2013-2018)

10.2 Global Tumor Treating Fields (TTFields) Market Forecast by Type (2018-2023)

10.3 Low Frequency Revenue Growth Rate (2013-2023)

10.4 Intermediate Frequency Revenue Growth Rate (2013-2023)

11 Global Tumor Treating Fields (TTFields) Market Segment by Application

11.1 Global Tumor Treating Fields (TTFields) Revenue Market Share by Application (2013-2018)

11.2 Tumor Treating Fields (TTFields) Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Clinics Revenue Growth (2013-2018)

11.5 Cancer and Radiation Therapy Centers Revenue Growth (2013-2018)

11.6 Others Revenue Growth (2013-2018)

12 Global Tumor Treating Fields (TTFields) Market Size Forecast (2018-2023)

12.1 Global Tumor Treating Fields (TTFields) Market Size Forecast (2018-2023)

12.2 Global Tumor Treating Fields (TTFields) Market Forecast by Regions (2018-2023)

12.3 North America Tumor Treating Fields (TTFields) Revenue Market Forecast (2018-2023)

12.4 Europe Tumor Treating Fields (TTFields) Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Tumor Treating Fields (TTFields) Revenue Market Forecast (2018-2023)

12.6 South America Tumor Treating Fields (TTFields) Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Tumor Treating Fields (TTFields) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Tumor Treating Fields (TTFields) Picture

Table Product Specifications of Tumor Treating Fields (TTFields)

Table Global Tumor Treating Fields (TTFields) and Revenue (

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery